Cultured Lung Fibroblasts from Ovalbumin-Challenged "asthmatic" Mice Differ Functionally from Normal.
Hisatoshi Sugiura,Xiangde Liu,Fenghai Duan,Shin Kawasaki,Shinsaku Togo,Koichiro Kamio,Xing Qi Wang,Lijun Mao,Youngsoo Ahn,Ronald F. Ertl,Tom W. Bargar,Abdo Berro,Thomas B. Casale,Stephen I. Rennard
DOI: https://doi.org/10.1165/rcmb.2007-0089oc
IF: 7.748
2007-01-01
American Journal of Respiratory Cell and Molecular Biology
Abstract:Asthmatic airway remodeling is characterized by goblet cell hyperplasia, angiogenesis, smooth muscle hypertrophy, and subepithelial fibrosis. This study evaluated whether acquired changes in fibroblast phenotype could contribute to this remodeling. Airway and parenchymal fibroblasts from control or chronically ovalbumin (OVA)-sensitized and challenged "asthmatic" mice were assessed for several functions related to repair and remodeling +/- exogenous transforming growth factor (TGF)-beta. All OVA-challenged mouse fibroblasts demonstrated augmented gel contraction (P < 0.05) and chemotaxis (P < 0.05); increased TGF-beta(1) (P < 0.05), fibronectin (P < 0.05), and vascular endothelial growth factor (P < 0.05) release; and expressed more alpha-smooth muscle actin (P < 0.05). TGF-beta(1) stimulated both control and asthmatic fibroblasts, which retained all differences from control fibroblasts for all features(P < 0.05, all comparisons). Parenchymal fibroblasts proliferated more rapidly (P < 0.05), while airway fibroblasts proliferated similarly compared with control fibroblasts (P = 0.25). Thus, in this animal model, OVA-challenged mouse fibroblasts acquire a distinct phenotype that differs from control fibroblasts. The augmented profibrotic activity and mediator release of asthmatic fibroblasts could contribute to airway remodeling in asthma.